Dr. Bishal Gyawali from the Institute of Cancer Policy, London and Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, discusses an editorial he authored that was published by Oncotarget in Volume 8, Issue 52, entitled, "Cancer drugs in LMICs: cheap but unaffordable."
Sign up for free Altmetric alerts about this article
DOI - https://doi.org/10.18632/oncotarget.21976
Full text - https://www.oncotarget.com/article/21976/
Correspondence to - Bishal Gyawali - [email protected]
Keywords - value, affordability, global oncology, drug prices, cancer
Copyright © 2025 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC